scPharmaceuticals Inc (NASDAQ: SCPH) stock jumped 4.58% on Friday to $5.25 against a previous-day closing price of $5.02. With 0.83 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.23 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $5.26 whereas the lowest price it dropped to was $4.96. The 52-week range on SCPH shows that it touched its highest point at $12.75 and its lowest point at $4.63 during that stretch. It currently has a 1-year price target of $18.67. Beta for the stock currently stands at 0.09.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SCPH was up-trending over the past week, with a rise of 6.92%, but this was down by -10.26% over a month. Three-month performance dropped to -33.63% while six-month performance fell -53.12%. The stock lost -19.60% in the past year, while it has lost -26.78% so far this year. A look at the trailing 12-month EPS for SCPH yields -1.36 with Next year EPS estimates of -1.17. For the next quarter, that number is -0.42. This implies an EPS growth rate of -14.49% for this year and 21.39% for next year.
Float and Shares Shorts:
At present, 34.26 million SCPH shares are outstanding with a float of 23.55 million shares on hand for trading. On Oct 30, 2023, short shares totaled 6.53 million, which was 18.21% higher than short shares on Sep 28, 2023. In addition to Mr. John H. Tucker as the firm’s President, CEO, Principal Executive Officer & Director, Ms. Rachael Nokes serves as its CFO & Principal Accounting Officer.
Through their ownership of 75.58% of SCPH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 50.49% of SCPH, in contrast to 40.77% held by mutual funds. Shares owned by individuals account for 14.29%. As the largest shareholder in SCPH with 9.20% of the stake, RTW Investments LP holds 3,297,843 shares worth 3,297,843. A second-largest stockholder of SCPH, Rubric Capital Management LP, holds 2,713,287 shares, controlling over 7.57% of the firm’s shares. AIGH Capital Management LLC is the third largest shareholder in SCPH, holding 2,207,009 shares or 6.16% stake. With a 2.09% stake in SCPH, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 749,134 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 1.83% of SCPH stock, is the second-largest Mutual Fund holder. It holds 655,894 shares valued at 3.51 million. SPDR S&P Kensho New Economies Com holds 1.55% of the stake in SCPH, owning 554,490 shares worth 2.97 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SCPH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SCPH analysts setting a high price target of $25.00 and a low target of $16.00, the average target price over the next 12 months is $18.67. Based on these targets, SCPH could surge 376.19% to reach the target high and rise by 204.76% to reach the target low. Reaching the average price target will result in a growth of 255.62% from current levels.
Summary of Insider Activity:
Insiders traded SCPH stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 3 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 840,745 while 0 shares were sold.